Strikingly, recent data suggest that SARS-CoV2 infection can lead to a deterioration in glycemic control, involving both profound insulin resistance (requiring as much as 50–100 U insulin/h) and impaired insulin secretion, together leading to diabetic ketoacidosis, DKA (61, 62). This evidence concerns the gene INS and diabetic ketoacidosis.